Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Combined Implementation of Dural Puncture Epidural and Programmed Intermittent Epidural Bolus for Labor Analgesia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03366935
Recruitment Status : Completed
First Posted : December 8, 2017
Last Update Posted : August 1, 2018
Sponsor:
Information provided by (Responsible Party):
Shanghai First Maternity and Infant Hospital

Brief Summary:
This study intends to carry out a prospective, randomized double-blind study to evaluate the safety and efficacy of the combined implementation of Dural puncture epidural (DPE) technique and Programmed intermittent epidural bolus (PIEB) for labor analgesia.

Condition or disease Intervention/treatment Phase
Labor Pain Labor Analgesia Other: EPL and CEI Other: DPE and CEI Other: DPE and PIEB Not Applicable

Detailed Description:
Epidural (EPL) technique is the standard technique for labor analgesia, but can be associated with slow onset and inadequate sacral spread, unilateral or patchy sensory blockade, motor impairment. The combined spinal epidural (CSE) technique can provide rapid onset of analgesia, but is associated with greater side effects, including pruritus, fetal bradycardia and delayed testing of epidural catheters. Dural puncture epidural (DPE) technique is a modification of CSE technique. A spinal needle is introduced through the epidural needle to create a single dural puncture , after intrathecal space was identified by the free flow of cerebrospinal fluid (CSF) , the needle was removed without direct medication administration into the subarachnoid space. Privous studies have demonstrated that the DPE technique can improve block quality over the EPL technique with fewer maternal and fetal side effects than the CSE technique for parturients requesting labor analgesia. Besides the neuraxial techniques, maintenance regimens is another factor that affect the analgesic effect. Programmed intermittent epidural bolus (PIEB) provides greater spread of local anesthetic solution within the epidural space and therefore superior quality of analgesia compared with continuous epidural infusion (CEI). We designed this prospective randomized, double-blind study to evaluate the safety and efficacy of the combined implementation of DPE technique and PIEB for labor analgesia.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Combined Implementation of Dural Puncture Epidural Technique and Programmed Intermittent Epidural Bolus for Labor Analgesia
Actual Study Start Date : October 10, 2017
Actual Primary Completion Date : June 8, 2018
Actual Study Completion Date : June 30, 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: EPL and CEI
Those with receive a standard epidural (EPL) and continuous epidural infusion(CEI) + patient-controlled epidural analgesia (PCEA)
Other: EPL and CEI

Procedure: Standard epidural placement(EPL)

Drug: ropivacaine Drug: sufentani 0.1% ropivacaine + sufentanil 0.3μg/mL

Device: Infusion pump Infusion pump set to continuous epidural infusion(CEI) plus patient-controlled epidural analgesia (PCEA).


Active Comparator: DPE and CEI
Those with receive a dural puncture labor epidural (DPE) and continuous epidural infusion(CEI) + patient-controlled epidural analgesia (PCEA)
Other: DPE and CEI

Procedure: Dural puncture epidural (DPE) Epidural with spinal needle placed to create a single dural puncture and confirm free flow of cerebral spinal fluid (CSF) , without direct medication administration into the subarachnoid space.

Drug: ropivacaine Drug: sufentani 0.1% ropivacaine + sufentanil 0.3μg/mL

Device: Infusion pump Infusion pump set to continuous epidural infusion(CEI) plus patient-controlled epidural analgesia (PCEA).


Active Comparator: DPE and PIEB
Those with receive a dural puncture labor epidural (DPE) and programmed intermittent epidural boluses(PIEB) + patient-controlled epidural analgesia (PCEA)
Other: DPE and PIEB

Procedure: Dural puncture epidural (DPE) Epidural with spinal needle placed to create a single dural puncture and confirm free flow of cerebral spinal fluid (CSF) , without direct medication administration into the subarachnoid space.

Drug: ropivacaine Drug: sufentani 0.1% ropivacaine + sufentanil 0.3μg/mL

Device: Infusion pump Infusion pump set to programmed intermittent epidural boluses (PIEB) plus patient-controlled epidural analgesia (PCEA).





Primary Outcome Measures :
  1. Compare time of onset of labor analgesia among the study groups [ Time Frame: From epidural infusion initiate to delivery ]
    Visual Numerical Rating Scale (VNRS) ≤ 10 mm on a 100-mm scale


Secondary Outcome Measures :
  1. Incidence of side effect [ Time Frame: 24 hours post delivery ]
    maternal hypotension,fetal bradycardia, maternal motor block,post-dural puncture headache,nausea, vomiting,pruritus,nerve damage

  2. Sensory block level [ Time Frame: 24 hours post delivery ]
    Sensory block will be assessed bilaterally

  3. Total anesthetic dose required [ Time Frame: From epidural infusion initiate to 1h post delivery ]
    Including physician interventions, programmed doses, and patient controlled doses

  4. Mode of delivery [ Time Frame: From epidural infusion initiate to delivery ]
    Spontaneous, Instrumental, or cesarean delivery

  5. Apgar scores [ Time Frame: 30 mins post delivery ]
    The Apgar scale is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10. The five criteria are skin color, pulse rate, reflex irritability grimace, activity and respiratoty effort



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Pregnant patients
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. women requeste labor analgesia
  2. ASA I or II
  3. at 37-42 weeks' gestation
  4. nulliparous
  5. singleton pregnancy, vertex presentation
  6. visual Numerical Rating Scale (VNRS) at requesting analgesia > 5 (NRPS 0-10)
  7. cervical dilatation < 5 cm

Exclusion Criteria:

  1. patient refusal to participate in the study
  2. age <20 years or >40 years
  3. body mass Index(BMI)>50 (Kg/m2)
  4. clinically significant diseases of pregnancy (i.e.,gestational hypertension, preeclampsia, gestational placenta previa, placental abruption diabetes)
  5. contraindications to neuraxial analgesia
  6. drug abuse
  7. conditions associated with an increased risk of a cesarean delivery (i.e., history of uterine anomaly or surgery, morbid obesity) and known anomalies

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03366935


Locations
Layout table for location information
China
Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine
Shanghai, China
Sponsors and Collaborators
Shanghai First Maternity and Infant Hospital
Investigators
Layout table for investigator information
Study Chair: YuJie Song, MD Department of Anesthesiaology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Shanghai First Maternity and Infant Hospital
ClinicalTrials.gov Identifier: NCT03366935    
Other Study ID Numbers: anesthesia dapartment
First Posted: December 8, 2017    Key Record Dates
Last Update Posted: August 1, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Shanghai First Maternity and Infant Hospital:
labor analgesia
dural puncture epidural (DPE)
standard Epidural (EPL)
continuous epidural infusion (CEI)
programmed intermittent epidural bolus (PIEB)
Additional relevant MeSH terms:
Layout table for MeSH terms
Labor Pain
Neurologic Manifestations
Pain